Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XON - Intrexon Corporation

Previous close
4.63
0   0%

Share volume: 0
Last Updated: Fri 31 Jan 2020 06:00:00 AM CET
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
$4.63
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 25%
Dept financing 17%
Liquidity 23%
Performance 52%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$4.63
P/E Ratio 
N/A
DAY RANGE
$4.63 - $4.63
EPS 
-$3.58
52 WEEK RANGE
$4.62 - $4.85
52 WEEK CHANGE
$0.00
MARKET CAP 
756.476 M
YIELD 
N/A
SHARES OUTSTANDING 
162.683 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$64,906,613
AVERAGE 10 VOLUME 
$745,377
AVERAGE 30 VOLUME 
$745,377
Company detail
CEO: Helen Sabzevari
Region: US
Website: http://www.dna.com
Employees: 882
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Intrexon Corp. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Recent news